Ella immunoassay platform gains CE‑IVD approval in the EU

HanchorBio's HCB101 receives US FDA Orphan Drug Designation in gastric cancer

Innovent reports first participant dosed in Phase 3 trial of IBI354 for first-line treatment of HER2-positive breast cancer

Celyad Oncology sells C-Cathez catheter to CellProthera

Citius Oncology signs LYMPHIR distribution agreement with Uniphar

IP Group plc portfolio company Microbiotica reports positive Phase 1b data for MB310 in ulcerative colitis

Ribo and Madrigal sign global siRNA licensing deal

BillionToOne launches two new add-on liquid biopsy applications for Northstar Select

Iterion Therapeutics reports first patient dosed in clinical study of tegavivint

Lunai Bioworks starts new oncology collaboration with clinical-stage partner

Median Technologies secures FDA clearance for AI lung cancer screening software

Insilico Medicine names new vice president, Clinical Development – Oncology

Kelun-Biotech reports fourth indication for sac-TMT approved by NMPA in HR+/HER2- breast cancer

Innovent Biologics collaborates with Eli Lilly to develop new oncology and immunology treatments

K36 Therapeutics completes first patient cohort dosing for Phase 1 trial of KTX-2001